IL122340A0 - Helicobacter pylori antigens and vaccine compositions - Google Patents

Helicobacter pylori antigens and vaccine compositions

Info

Publication number
IL122340A0
IL122340A0 IL12234096A IL12234096A IL122340A0 IL 122340 A0 IL122340 A0 IL 122340A0 IL 12234096 A IL12234096 A IL 12234096A IL 12234096 A IL12234096 A IL 12234096A IL 122340 A0 IL122340 A0 IL 122340A0
Authority
IL
Israel
Prior art keywords
helicobacter pylori
vaccine compositions
pylori antigens
antigens
vaccine
Prior art date
Application number
IL12234096A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL122340A0 publication Critical patent/IL122340A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12234096A 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions IL122340A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
IL122340A0 true IL122340A0 (en) 1998-04-05

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12234096A IL122340A0 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Country Status (22)

Country Link
US (2) US6025164A (es)
EP (1) EP0828757A1 (es)
JP (1) JP3380559B2 (es)
KR (1) KR19990022131A (es)
CN (1) CN1191544A (es)
AR (1) AR003125A1 (es)
BR (1) BR9608627A (es)
CA (1) CA2222797A1 (es)
CZ (1) CZ357397A3 (es)
EE (1) EE9700306A (es)
HU (1) HUP9901546A3 (es)
IL (1) IL122340A0 (es)
IS (1) IS4615A (es)
MY (1) MY119003A (es)
NO (1) NO975490L (es)
NZ (1) NZ303356A (es)
PL (1) PL323741A1 (es)
RU (1) RU2195463C2 (es)
SK (1) SK155297A3 (es)
TR (1) TR199701471T1 (es)
TW (1) TW570925B (es)
WO (1) WO1996038475A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US6258359B1 (en) 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
NZ269124A (en) * 1993-07-27 1997-06-24 Csl Ltd Vaccine comprising helicobacter antigens and its use in treating such infections
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
PL324826A1 (en) * 1995-06-07 1998-06-22 Astra Ab Sequences of nucleic acids and amino acids associated with heliobacter pylori for use in diagnostics and therapy
EP0971734A4 (en) * 1997-03-26 2001-02-07 Avant Immunotherapeutics Inc CARBOHYDRATE ANTIGENS HAVING IMMUNOLOGICAL REACTIVITY WITH POLYCLONAL ANTISERUMS AGAINST H. PYLORI
JP2002512619A (ja) * 1997-04-30 2002-04-23 メリウクス オラバクス 横隔膜下からの全身経路に使用するための抗ヘリコバクターワクチン組成物、および粘膜／非経口複合免疫法
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
DE69922364T2 (de) * 1998-04-30 2005-11-03 Chiron S.R.L. Verfahren zur Immunisierung gegen und zur Behandlung von Infektionen durch H.pylori
AU3205000A (en) * 1999-02-19 2000-09-04 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US20030180330A1 (en) * 2000-04-27 2003-09-25 Meyer Thomas F Method for identifying helicobacter antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
AU2004266213A1 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
US20090269362A1 (en) * 2005-07-25 2009-10-29 Sant Andrea J Method for Controlling Immunodominance
WO2009014782A2 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
WO2017102779A1 (en) 2015-12-14 2017-06-22 Technische Universität München Helicobacter pylori vaccines
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110965T1 (de) * 1989-03-09 1994-09-15 Praxis Biolog Inc Impfstoffe gegen hämophilus influenzae.
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
AR003125A1 (es) 1998-07-08
TR199701471T1 (xx) 1998-02-21
EE9700306A (xx) 1998-06-15
HUP9901546A3 (en) 2003-07-28
IS4615A (is) 1997-11-17
NZ303356A (en) 1999-05-28
WO1996038475A1 (en) 1996-12-05
JP3380559B2 (ja) 2003-02-24
MY119003A (en) 2005-03-31
TW570925B (en) 2004-01-11
MX9709194A (es) 1998-07-31
US20020168726A1 (en) 2002-11-14
JPH11507210A (ja) 1999-06-29
EP0828757A1 (en) 1998-03-18
AU703331B2 (en) 1999-03-25
NO975490L (no) 1998-01-07
CN1191544A (zh) 1998-08-26
NO975490D0 (no) 1997-11-28
HUP9901546A2 (hu) 1999-08-30
CZ357397A3 (cs) 1998-05-13
US6025164A (en) 2000-02-15
KR19990022131A (ko) 1999-03-25
BR9608627A (pt) 1999-06-15
AU6020596A (en) 1996-12-18
CA2222797A1 (en) 1996-12-05
RU2195463C2 (ru) 2002-12-27
PL323741A1 (en) 1998-04-14
SK155297A3 (en) 1998-08-05

Similar Documents

Publication Publication Date Title
IL122340A0 (en) Helicobacter pylori antigens and vaccine compositions
RU98100200A (ru) Антигены helicobacter pylori и вакцинные композиции
IL118004A0 (en) Vaccine compositions
AU2829995A (en) Detection of helicobacter pylori
IL117249A0 (en) Vaccine compositions
EP0754057A4 (en) COMPOSITIONS AND METHODS FOR OBTAINING VACCINES COMPRISING ALPHA-GALACTOSYL EPITOPES
EP0821698A4 (en) PROTECTIVE HELIOBACTER ANTIGENES
IL117623A0 (en) Maltitol compositions and its preparation
AU2126495A (en) Recombinase-deficient (helicobacter pylori) and related methods
AU5160596A (en) Helicobacter pylori cagi region
AU1698699A (en) (helicobacter pylori) vaccine formulations
AU3189795A (en) Mouse model for helicobacter pylori infection
CZ20011896A3 (cs) Imunogenní prostředek a protilátka
NZ238674A (en) Antibody compositions specific for helicobacter pylori
AU7137896A (en) Helicobacter pylori protein
IL133144A0 (en) Vaccine compositions comprising the helicobacter pylori flge polypeptide
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
GB9413050D0 (en) Helicobacter pylori carbonic anhydrase-like protein
IL116542A0 (en) Helicobacter pylori antigenic protein preparation and immunoassay
ZA955500B (en) Helicobacter pylori antigenic protein preparation and immunoassays
ZA963133B (en) Protective helicobacter antigens
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
AU5262196A (en) Protective helicobacter antigens
IL116541A (en) Helicobacter proteins and vaccines